| |
| |
|
| Insider
Information: |
Odink Debra |
| Relationship: |
|
| City: |
Hayward |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
7,896 |
|
|
Indirect Shares
|
13,855 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
21,751 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Anthera Pharmaceuticals Inc |
ANTH |
|
2015-10-12 |
7,896 |
2015-10-12 |
13,855 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ANTH |
Anthera Pharmaceuticals I... |
Chief Technology Officer |
• – – |
2015-10-12 |
4 |
AS |
$6.15 |
$7,411 |
D/D |
(1,205) |
7,896 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Technology Officer |
• – – |
2014-12-30 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,364 |
13,855 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Technology Officer |
• – – |
2014-12-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,364 |
9,101 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Technology Officer |
• – – |
2014-03-25 |
4 |
D |
$3.30 |
$9,184 |
D/D |
(2,783) |
6,601 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Technology Officer |
• – – |
2014-03-25 |
4 |
D |
$3.30 |
$9,184 |
D/D |
(2,783) |
6,601 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Technology Officer |
• – – |
2014-03-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,864 |
10,465 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Technology Officer |
• – – |
2014-03-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,864 |
10,465 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Technology Officer |
• – – |
2013-06-30 |
4 |
D |
$0.49 |
$1,102 |
D/D |
(2,248) |
75,074 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Technology Officer |
• – – |
2013-03-25 |
4 |
A |
$0.00 |
$0 |
D/D |
49,519 |
77,322 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Technology Officer |
• – – |
2013-01-10 |
4 |
GA |
$0.00 |
$0 |
I/I |
4,009 |
99,937 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Technology Officer |
• – – |
2013-01-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,009 |
27,803 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Technology Officer |
• – – |
2013-01-03 |
4 |
D |
$0.69 |
$2,352 |
D/D |
(3,409) |
31,812 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Technology Officer |
• – – |
2012-06-30 |
4 |
D |
$0.69 |
$1,268 |
D/D |
(1,838) |
24,821 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Technology Officer |
• – – |
2012-03-01 |
4 |
AS |
$6.57 |
$13,140 |
D/D |
(2,000) |
26,659 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Technology Officer |
• – – |
2012-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
7,418 |
28,659 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Technology Officer |
• – – |
2012-01-10 |
4 |
AS |
$6.51 |
$5,205 |
D/D |
(800) |
23,241 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Technology Officer |
• – – |
2012-01-06 |
4 |
AS |
$6.50 |
$7,800 |
D/D |
(1,200) |
24,441 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
VP, Pharmaceutical R&D |
• – – |
2011-06-30 |
4 |
D |
$8.17 |
$29,984 |
D/D |
(3,670) |
25,641 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
VP, Pharmaceutical R&D |
• • – |
2011-04-13 |
4 |
OE |
$1.51 |
$5,000 |
D/D |
3,311 |
29,311 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
VP, Pharmaceutical R&D |
• – – |
2010-09-24 |
4 |
B |
$4.20 |
$4,200 |
D/D |
1,000 |
26,000 |
2.66 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
VP, Pharmaceutical R&D |
• – – |
2010-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
VP, Pharmaceutical R&D |
• – – |
2010-03-04 |
4 |
A |
$0.00 |
$0 |
I/I |
17,523 |
95,928 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
VP, Pharmaceutical R&DOfficer |
• – – |
2010-02-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
78,405 |
|
- |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
